Popular Articles
Natural Remedies

PIH Founder Farmer Discussing Possible Appointment To Coordinate U.S. Global Health Initiatives, Boston Globe Reports
Paul Farmer -- founder of Partners in Health and vice chair of the Department of Global Health and Social Medicine at Harvard Medical School -- said he is in discussions with the State Department about a possible Obama administration appointment to coordinate U.S. global health initiatives, the Boston Globe reports. Farmer made the announcement Monday during a meeting with HMS faculty. Farmer said that he has not decided whether he will accept the appointment if he receives a formal offer but that he is considering it, according to the Globe. The Globe reports that it was unable to confirm whether Farmer is being considered for a full-time policy position or for an advisory role or if the appointment would be a new or existing position. Several top positions at USAID -- including administrator, deputy administrator and the assistant administrator in charge of global health are vacant, the Globe reports. These positions are presidential appointments and would require Senate confirmation. In addition, Farmer could be discussing health policy positions with the State Department. Farmer did not respond for requests seeking comment. PIH and HMS also declined comment. A spokesperson at the State Department would not discuss personnel discussions that are in progress or possible new positions. Laurie Garrett, a global health policy specialist at the Council on Foreign Relations, said the administration"s announcement last week of a $63 billion, six-year initiative that aims to address HIV/AIDS, tuberculosis, malaria and other illnesses could allow new appointees the opportunity to make a significant impact in U.S. global health policy. Garrett, who has known Farmer for several years, added that she would be surprised if he is considering a government position in part because of his extensive involvement with PIH (Smith, Boston Globe, 5/15).
generic viagra online
Early Mental Illness May Be Revealed By MRI Mapping Of Brain
John Csernansky wants to take your measurements. Not the circumference of your chest, waist and hips. No, this doctor wants to stretch a tape measure around your hippocampus, thalamus and prefrontal cortex.
News of the day
American Cancer Society Forum To Address Cancer's Economic Impact On The Workforce
The American Cancer Society will host its inaugural Corporate Impact Conference June 18-19 in Chicago to help large corporate employers diminish the impact of cancer on the workforce and help improve workplace productivity. "Companies Changing the Course of Cancer" is designed to guide businesses in potentially lowering health care costs related to cancer and improving their overall bottom line.
Cardiovascular

New Test For Safer Biomedical Research Results

In cancer research, as in most other biomedical sciences, they are playing a key role: living cells, kept in sterile plastic containers with red culture media populating incubators in laboratories around the world. But do researchers always know what is really living in their culture dishes? Under the microscope, different cell lines are almost impossible to distinguish from each other. When these important research objects stop growing without apparent reason - is it because of the manipulations by the scientists or because of an invisible viral or bacterial infection? Contaminations with other cell lines or pathogenic agents are a common and well-known problem. Often they are the reason why cell experiments fail to produce useable or reproducible results. Even worse, laboratory staff can get infected with dangerous pathogens from a cell culture. To make those important cell culture experiments safer, DKFZ researchers Dr. Markus Schmitt and Dr. Michael Pawlita have developed a test which is able to identify 37 different cell contaminations in a single run. The researchers have tested the system in over 700 samples from different research labs and have now published their results. The method called "Multiplex cell Contamination Test" (McCT) detects not only wide-spread viruses but also a number of mycoplasmas, which are considered the major contaminators of cell cultures. In addition, the test checks the cells for their origin. Thus, if dog genetic material is found in what are supposed to be monkey cells, then a contamination of the cell culture is obvious. The test also includes detection of commonly used standard cell lines. Contamination with the fast-growing cancer cell line HeLa, for example, is a dreaded of false results. Pawlita and Schmitt found contaminations in a high percentage of cell samples. Twenty-two percent of tested cultures were contaminated with one of the various types of the parasitic bacterium called mycoplasma. "What we noticed about the results," says Markus Schmitt, "was that contaminations were frequent in some laboratories, while others sent in cultures that were constantly clean. Thus, care in laboratory work seems to play an important role." The test is highly specific and needs no more than ten copies of foreign DNA in the cell sample to be positive. This is a sensitivity which is comparable to or even higher than those of previously available commercial mycoplasma tests. McCT results are reproducible to 99.6 percent. The method is based on multiplication of specific DNA sequences by polymerase chain reaction and subsequent detection of the multiplied DNA regions. A special advantage of the new test is that it can be carried out on a high-throughput basis. The DKFZ researchers can manage up to 1,000 tests per week. Markus Schmitt und Michael Pawlita: High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Research 2009, DOI: 10.1093/nar/gkp581 Dr. Sibylle Kohlstç¤dt Helmholtz Association of German Research Centres


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):